Smokeless tobacco cessation interventions: A systematic review
- PMID: 30666002
- PMCID: PMC6362721
- DOI: 10.4103/ijmr.IJMR_1983_17
Smokeless tobacco cessation interventions: A systematic review
Abstract
Background & objectives: Smokeless tobacco (SLT) consumption is a global health issue with about 350 million users and numerous adverse health consequences like oral cancer and myocardial disorders. Hence, cessation of SLT use is as essential as smoking cessation. An update on the available literature on SLT cessation intervention studies is provided here.
Methods: Through an extensive literature search on SLT cessation intervention studies, using keywords such as smokeless tobacco, cessation, interventions, quitlines, brief advice, nicotine replacement therapy, nicotine gum, nicotine lozenge, nicotine patch, bupropion, varenicline, mHealth, etc., 59 eligible studies were selected. Furthermore, efficacy of the interventions was assessed from the reported risk ratios (RRs) [confidence intervals (CIs)] and quit rates.
Results: Studies were conducted in Scandinavia, India, United Kingdom, Pakistan and the United States of America, with variable follow up periods of one month to 10 years. Behavioural interventions alone showed high efficacy in SLT cessation; most studies were conducted among adults and showed positive effects, i.e. RR [CI] 0.87 [0.7, 1.09] to 3.84 [2.33, 6.33], quit rate between 9-51.5 per cent, at six months. Regular telephone support/quitlines also proved beneficial. Among pharmacological modalities, nicotine lozenges and varenicline proved efficacious in SLT cessation.
Interpretation & conclusions: Globally, there is limited information available on SLT cessation intervention trials, research on which must be encouraged, especially in the low-resource, high SLT burden countries; behavioural interventions are most suitable for such settings. Appropriate training/sensitization of healthcare professionals, and school-based SLT use prevention and cessation programmes need to be encouraged.
Keywords: Behavioural; intervention; nicotine replacement therapy; smokeless tobacco; tobacco dependence; tobacco use cessation.
Conflict of interest statement
None
Figures
References
-
- Singh PK. Smokeless tobacco use and public health in countries of South-East Asia region. Indian J Cancer. 2014;51(Suppl 1):S1–2. - PubMed
-
- WHO Framework Convention on Tobacco Control. Guidelines for Implementation of Article 14 of the WHO Framework Convention on Tobacco Control (Demand reduction Measures Concerning tobacco Dependence and Cessation) [accessed on May 4, 2017]. Available from: http://www.who.int/fctc/Guidelines.pdf .
-
- Raw M. Framework convention on tobacco control (FCTC) article 14 guidelines: A new era for tobacco dependence treatment. Addiction. 2011;106:2055–7. - PubMed
-
- WHO Framework Convention on Tobacco Control. 2016 Global Progress Report on Implementation of the WHO Framework Convention on Tobacco Control. [accessed on June 7, 2017]. Available from: http://www.who.int/fctc/reporting/2016_global_progress_report.pdf?ua=1 .
-
- WHO Framework Convention on Tobacco Control. Global Progress Report on Implementation of the WHO Framework Convention on Tobacco Control. 2014. [accessed on June 7, 2017]. Available from: http://www.who.int/fctc/reporting/2014globalprogressreport.pdf?ua=1 .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical